- Pfizer, Moderna or J&J? An Expert Answers Your Questions
- Fauci Says Relaxed Indoor Masking Rules Could Be on the Way
- Health Highlights: May 10, 2021
- Feeling Down? Support Via Social Media May Not Be Enough
- COVID Vaccines May Still Leave Organ Transplant Recipients Unprotected
- COVID-19 Appears to Have No Lasting Impact on College Athletes’ Hearts
- Lockdown Loneliness Making Things Even Tougher for Cancer Patients
- Pregnancy Within 1 Year of Weight-Loss Surgery Carries Added Risks
- Why Sleep Raises Risk for Sudden Death in People With Epilepsy
- Asthma Attacks Plummeted During Pandemic
Acne Drug May Help in the Fight Against AIDS
FRIDAY, March 19A cheap acne drug that’s been used for decades appears to target infected immune-system cells in which HIV lies dormant before coming back to life and spreading infection, researchers have found.
The authors of a new study say the antibiotic drug, minocycline, sold under names such as Minocin, could add to the HIV-fighting powers of existing AIDS drug regimens.
“The big challenge clinicians deal with now in this country when treating HIV patients is keeping the virus locked in a dormant state,” Janice Clements, professor of molecular and comparative pathobiology at the Johns Hopkins University School of Medicine, said in a news release. While existing drugs are “really effective in keeping down active replication, minocycline is another arm of defense against the virus,” she added.
Clements said minocycline targets immune cells known as T cells and makes it harder for them to reproduce. That, in turn, makes it harder for HIV to spread and eventually cause AIDS.
“This drug strikes a good balance and is ideal for HIV because it targets very specific aspects of immune activation,” Gregory Szeto, a graduate student who works at the Retrovirus Laboratory at Hopkins, said in the news release.
The study findings have been released online in advance of publication in the April 15 print issue of the Journal of Infectious Diseases.
More information
The U.S. Department of Health and Human Services has a primer on AIDS drugs.
Source: HealthDay
